EUVIMEDOpdag EUVIMED
Crossref

Prenatal Diagnostic Testing for Adult‐Onset Neurodegenerative Disease

Maya Rawal iD, Stephanie Galloway, Michelle E Florido, Amanda L Bergner, Ronald Wapner, Jill S Goldman

Prenatal Diagnosis · 2025

DOI: 10.1002/pd.6826 ↗

At a glance

Journal article in Prenatal Diagnosis, 2025. Written by Maya Rawal and 5 co-authors. Institution: Program in Genetic Counseling, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA. Major MEDLINE topics: Neurodegenerative Diseases, Prenatal Diagnosis, Genetic Testing. 27 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

This study investigated existing practices and institutional guidelines on prenatal diagnostic testing (PND) for adult‐onset neurodegenerative disease (AOND) to identify points of consensus, disparities, and areas of need in healthcare settings across the United States (US) to better understand if national guidelines are needed.

Methods

A questionnaire about institutional practices and guidelines on PND for AOND was distributed through the National Society of Genetic Counselors, Society for Maternal‐Fetal Medicine, and Huntington's Disease Society of America Centers of Excellence. Of 104 responses, 50 met eligibility criteria and were analyzed for commonalities and shared themes.

Results

Of those who provided responses, 80% reported that their institution does not have a formal protocol or written guidelines on PND for AOND. Challenges to PND for AOND included ethical decision making after a positive genetic result, double disclosure of fetal and parental status, and differing values among relevant stakeholders. Of those who provided responses, 100% indicated that national guidelines would be beneficial.

Conclusion

This study helps establish the need for national guidelines on PND for AOND given that most institutions surveyed do not have standardized protocols. Points of consensus and shared areas of uncertainty may serve as starting points for the formation of national practice guidelines.

Subjects

MeSH terms (MEDLINE)

Neurodegenerative DiseasesPrenatal DiagnosisGenetic TestingHumansFemalePregnancyAdultSurveys and QuestionnairesPractice Guidelines as TopicUnited States

Authors and institutions

  • Program in Genetic Counseling, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Division of Women's Genetics, Department of Obstetrics & Gynecology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Department of Genetics and Development, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.

ORCID profiles: Maya Rawal

Cite

APA

Rawal, M., Galloway, S., Florido, M. E., Bergner, A. L., Wapner, R., & Goldman, J. S. (2025). Prenatal Diagnostic Testing for Adult‐Onset Neurodegenerative Disease. Prenatal Diagnosis. https://doi.org/10.1002/pd.6826

Vancouver

Rawal M, Galloway S, Florido ME, Bergner AL, Wapner R, Goldman JS. Prenatal Diagnostic Testing for Adult‐Onset Neurodegenerative Disease. Prenatal Diagnosis. 2025. doi:10.1002/pd.6826

BibTeX
@article{Rawal2025,
  author = {Rawal, Maya and Galloway, Stephanie and Florido, Michelle E and Bergner, Amanda L and Wapner, Ronald and Goldman, Jill S},
  title = {Prenatal Diagnostic Testing for Adult‐Onset Neurodegenerative Disease},
  journal = {Prenatal Diagnosis},
  year = {2025},
  doi = {10.1002/pd.6826}
}
Start for free →